MRNA | Moderna Therapeutics
AstraZeneca will sell its vaccine to governments at significantly lower prices as compared to Pfizer and Moderna.
Pfizer shares fell nearly 3 percent in the pre-market trading Monday following Moderna’s announcement.
The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.
Moderna has received approximately $400 million of customer deposits as of July 31, 2020 for potential supply of mRNA-1273.
